导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 14.48% | 15/158 |
| 近一周 | -1.80% | 9/164 |
| 近一月 | -3.43% | 64/164 |
| 近一季 | -4.84% | 63/164 |
| 近半年 | 18.18% | 11/160 |
| 近一年 | 17.92% | 14/155 |
| 近两年 | 44.15% | 43/130 |
| 近三年 | 82.86% | 2/100 |
| 成立以来 | 274.08% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.60% 163/360 |
26.39% 28/366 |
- - |
- - |
| 2025 | 17.92% 164/358 |
-7.94% 262/340 |
16.69% 46/348 |
8.10% 173/354 |
1.55% 79/358 |
| 2024 | 22.86% 67/329 |
8.11% 69/280 |
7.24% 76/310 |
1.95% 214/318 |
3.94% 98/329 |
| 2023 | 50.31% 31/275 |
19.20% 14/205 |
14.25% 43/230 |
-3.01% 53/262 |
13.80% 24/276 |
| 2022 | -32.09% 141/201 |
-9.01% 73/153 |
-21.55% 146/164 |
-4.60% 62/189 |
-0.27% 157/202 |
| 2021 | 25.08% 23/150 |
1.41% 162/312 |
10.63% 55/328 |
0.76% 64/358 |
10.64% 22/151 |
| 2020 | 42.88% 9/103 |
-11.65% 143/280 |
28.44% 53/295 |
12.29% 31/299 |
12.13% 93/305 |
| 2019 | 35.35% 15/88 |
15.64% 46/258 |
3.52% 72/268 |
0.90% 116/253 |
12.05% 37/266 |
| 2018 | -1.93% 24/79 |
- - |
- - |
- - |
-16.20% 182/241 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 南方恒生生物科技ETF(QDII) | 1.1206 | 25.14% |
| 华宝标普油气上游股票美元A | 0.1538 | 24.94% |
| 广发中证香港创新药ETF发起式联接(QDII)A | 1.3401 | 24.24% |
| 易方达纳斯达克100ETF联接(QDII-LOF)A(美元现汇) VS. 建信富时100指数(QDII)人民币A(539003) |